Literature DB >> 9564849

Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation.

M Silvy1, P M Martin, N Chajry, Y Berthois.   

Abstract

Epidermal growth factor (EGF), which plays an important role in normal and tumoral cell growth regulation, displays an ambivalent dose-dependent effect on the proliferation of epithelial cells overexpressing EGF receptor. However, the underlying molecular mechanisms remain obscure. In this study we have examined the regulation of amphiregulin (AR) gene expression by growth inhibitory (10(-9) M) and stimulatory (10(-12) M) EGF concentrations in A431 cells. The time course of AR messenger RNA (mRNA) accumulation was different with 10(-12) and 10(-9) M EGF; AR induction by 10(-9) M EGF peaked between 1 and 1.5 h, then decreased to the basal level within 2 h. Conversely, the induction by 10(-12) M EGF was slightly delayed, but persisted for 4 h. The involvement of tyrosine phosphorylation in AR induction by EGF was suggested by the ability of the tyrosine phosphatase inhibitor sodium orthovanadate to prolong AR expression induced by 10(-12) or 10(-9) M EGF. In the presence of the protein phosphatase 2A inhibitor, okadaic acid, 10(-9) M EGF induced a persistent accumulation of AR mRNA. On the contrary, okadaic acid abrogated the stimulation of AR mRNA level induced by a low EGF concentration, suggesting that both EGF concentrations activated distinct regulatory mechanisms. The signaling components involved in the differential activities of EGF in A431 cells were then examined. We previously reported a relationship between the ambivalent activity of EGF and the p42-mitogen-activated protein (MAP) kinase activity. Thus, 10(-12) M EGF induced a sustained MAP kinase activation, whereas 10(-9) M EGF led to a sharp, but transitory, activation. The MAP kinases are activated by MAP kinase kinases (MEK1 and MEK2). Whereas no significant effect of 10(-12) M EGF could be detected, 10(-9) M EGF was shown to activate MEK1 and, to a lesser extent, MEK2. Also, both MAP kinase activation and AR induction by 10(-9) M, but not by 10(-12) M, EGF were inhibited by the MEK1 inhibitor PD98059. Moreover, the involvement of c-Raf-1 in the signaling pathway induced by EGF was verified. A concentration of 10(-9) M EGF induced stimulation of c-Raf-1 kinase activity, whereas 10(-12) M EGF not only failed to activate c-Raf-1, but led to a moderate decrease in its kinase activity. These results demonstrate that in EGF receptor-overexpressing cells, EGF may differently affect gene expression and cell proliferation through distinct mechanisms of regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9564849     DOI: 10.1210/endo.139.5.5981

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death.

Authors:  P Dent; D B Reardon; J S Park; G Bowers; C Logsdon; K Valerie; R Schmidt-Ullrich
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  Consistency of the proteome in primary human keratinocytes with respect to gender, age, and skin localization.

Authors:  Adrian Sprenger; Sebastian Weber; Mostafa Zarai; Rudolf Engelke; Juliana M Nascimento; Christine Gretzmeier; Martin Hilpert; Melanie Boerries; Cristina Has; Hauke Busch; Leena Bruckner-Tuderman; Jörn Dengjel
Journal:  Mol Cell Proteomics       Date:  2013-05-30       Impact factor: 5.911

3.  Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells.

Authors:  M Silvy; C Giusti; P M Martin; Y Berthois
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

4.  Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3).

Authors:  Mohamed Amessou; Abdul Shukkur Ebrahim; Ashok Dilly; Melvin Joseph; Marina Tabolina; Sahiti Chukkapalli; Louay Meroueh; Joseph T Syed; Allison Liddane; Siera Lanae Lang; Ayad Al-Katib; Mustapha Kandouz
Journal:  Oncotarget       Date:  2016-11-29

5.  EGFR-dependent tyrosine phosphorylation of integrin β4 is not required for downstream signaling events in cancer cell lines.

Authors:  Lisa Te Molder; Maaike Kreft; Niels Heemskerk; Joyce Schuring; Jose M de Pereda; Kevin Wilhelmsen; Arnoud Sonnenberg
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

6.  Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine.

Authors:  Clémentine Dillard; Chloé Borde; Ammara Mohammad; Virginie Puchois; Laurent Jourdren; Annette K Larsen; Michèle Sabbah; Vincent Maréchal; Alexandre E Escargueil; Elodie Pramil
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.